The role of regulatory T-cells in glioma immunology

Clinical Neurology and Neurosurgery

Volumn 119, Issue , 2014, Pages 125-132

  Ooi, Yinn Cher ^a   Tran, Patrick ^a   Ung, Nolan ^a   Thill, Kimberly ^a   Trang, Andy ^a   Fong, Brendan M ^a   Nagasawa, Daniel T ^a   Lim, Michael ^b   Yang, Isaac ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Gliomas; Immunology; Regulatory T cells

Indexed keywords

CANCER VACCINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; DENDRITIC CELL VACCINE; INTERLEUKIN 10; INTERLEUKIN 2; MONOCLONAL ANTIBODY; SECONDARY LYMPHOID TISSUE CHEMOKINE; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA;

ACTIVE IMMUNIZATION; AUTOIMMUNITY; CANCER IMMUNOTHERAPY; CELLULAR IMMUNITY; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; DOWN REGULATION; EX VIVO STUDY; GLIOBLASTOMA; GLIOMA; HUMAN; HUMORAL IMMUNITY; HYPOXIA; IMMUNOSURVEILLANCE; IN VITRO STUDY; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTIC INFILTRATION; NONHUMAN; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVIEW;

GLIOMAS; IMMUNOLOGY; REGULATORY T-CELLS;

ANIMALS; BRAIN NEOPLASMS; GLIOBLASTOMA; GLIOMA; HUMANS; IMMUNE TOLERANCE; INTERLEUKIN-10; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA;

EID: 84897111120     PISSN: 03038467     EISSN: 18726968     Source Type: Journal    
DOI: 10.1016/j.clineuro.2013.12.004     Document Type: Review

References (121)

1. H.M. Fathallah-Shaykh, and D.D. McIntire Brain tumors in the elderly: undefeated and gaining ground Arch Neurol 55 1998 905 906 (Pubitemid 28335107)
2. A. El Andaloussi, and M.S. Lesniak CD4+ CD25+ FoxP3+ T-cell infiltration and heme oxygenase-1 expression correlate with tumor grade in human gliomas J Neurooncol 83 2007 145 152 (Pubitemid 46784987)
3. A.F. Carpentier, and Y. Meng Recent advances in immunotherapy for human glioma Curr Opin Oncol 18 2006 631 636 (Pubitemid 44427639)
4. A. El Andaloussi, Y. Han, and M.S. Lesniak Prolongation of survival following depletion of CD4+CD25+ regulatory T cells in mice with experimental brain tumors J Neurosurg 105 2006 430 437 (Pubitemid 44358755)
5. M.K. Levings, R. Sangregorio, C. Sartirana, A.L. Moschin, M. Battaglia, and P.C. Orban et al. Human CD25+CD4+ T suppressor cell clones produce transforming growth factor beta, but not interleukin 10, and are distinct from type 1 T regulatory cells J Exp Med 196 2002 1335 1346 (Pubitemid 35375552)
6. K.J. Maloy, and F. Powrie Regulatory T cells in the control of immune pathology Nat Immunol 2 2001 816 822
7. S. Sakaguchi, N. Sakaguchi, J. Shimizu, S. Yamazaki, T. Sakihama, and M. Itoh et al. Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance Immunol Rev 182 2001 18 32 (Pubitemid 33070205)
8. S. Paust, and H. Cantor Regulatory T cells and autoimmune disease Immunol Rev 204 2005 195 207 (Pubitemid 40460503)
9. I. Kryczek, K. Wu, E. Zhao, S. Wei, L. Vatan, and W. Szeliga et al. IL-17+ regulatory T cells in the microenvironments of chronic inflammation and cancer J Immunol 186 2011 4388 4395
10. C. Dejaco, C. Duftner, B. Grubeck-Loebenstein, and M. Schirmer Imbalance of regulatory T cells in human autoimmune diseases Immunology 117 2006 289 300
11. L. Gattinoni, D.J. Powell Jr., S.A. Rosenberg, and N.P. Restifo Adoptive immunotherapy for cancer: building on success Nat Rev Immunol 6 2006 383 393
12. D.T. Nagasawa, C. Fong, A. Yew, M. Spasic, H.M. Garcia, and C.A. Kruse et al. Passive immunotherapeutic strategies for the treatment of malignant gliomas Neurosurg Clin N Am 23 2012 481 495
13. L.H. Rome, and V.A. Kickhoefer Development of the vault particle as a platform technology ACS Nano 7 2013 889 902
14. Y. Belkaid, and B.T. Rouse Natural regulatory T cells in infectious disease Nat Immunol 6 2005 353 360 (Pubitemid 41716772)
15. L. Graca, T.C. Chen, A. Le Moine, S.P. Cobbold, D. Howie, and H. Waldmann Dominant tolerance: activation thresholds for peripheral generation of regulatory T cells Trends Immunol 26 2005 130 135 (Pubitemid 40312519)
16. R.K. Gershon, and K. Kondo Cell interactions in the induction of tolerance: the role of thymic lymphocytes Immunology 18 1970 723 737
17. M.G. Roncarolo, R. Bacchetta, C. Bordignon, S. Narula, and M.K. Levings Type 1 T regulatory cells Immunol Rev 182 2001 68 79 (Pubitemid 33070208)
18. I.M. de Kleer, L.R. Wedderburn, L.S. Taams, A. Patel, H. Varsani, and M. Klein et al. CD4+CD25bright regulatory T cells actively regulate inflammation in the joints of patients with the remitting form of juvenile idiopathic arthritis J Immunol 172 2004 6435 6443 (Pubitemid 38621253)
19. D. Cao, R. van Vollenhoven, L. Klareskog, C. Trollmo, and V. Malmstrom CD25brightCD4+ regulatory T cells are enriched in inflamed joints of patients with chronic rheumatic disease Arthritis Res Ther 6 2004 R335 R346
20. O. Boyer, D. Saadoun, J. Abriol, M. Dodille, J.C. Piette, and P. Cacoub et al. CD4+CD25+ regulatory T-cell deficiency in patients with hepatitis C-mixed cryoglobulinemia vasculitis Blood 103 2004 3428 3430 (Pubitemid 38525674)
21. M.S. Longhi, Y. Ma, D.P. Bogdanos, P. Cheeseman, G. Mieli-Vergani, and D. Vergani Impairment of CD4(+)CD25(+) regulatory T-cells in autoimmune liver disease J Hepatol 41 2004 31 37 (Pubitemid 39005149)
22. M.F. Liu, C.R. Wang, L.L. Fung, and C.R. Wu Decreased CD4+CD25+ T cells in peripheral blood of patients with systemic lupus erythematosus Scand J Immunol 59 2004 198 202
23. K. Furuno, T. Yuge, K. Kusuhara, H. Takada, H. Nishio, and V. Khajoee et al. CD25+CD4+ regulatory T cells in patients with Kawasaki disease J Pediatr 145 2004 385 390 (Pubitemid 39165689)
24. C.S. Hsieh, Y. Liang, A.J. Tyznik, S.G. Self, D. Liggitt, and A.Y. Rudensky Recognition of the peripheral self by naturally arising CD25+ CD4+ T cell receptors Immunity 21 2004 267 277 (Pubitemid 39094055)
25. R. Pacholczyk, H. Ignatowicz, P. Kraj, and L. Ignatowicz Origin and T cell receptor diversity of Foxp3+CD4+CD25+ T cells Immunity 25 2006 249 259
26. S.Z. Josefowicz, and A. Rudensky Control of regulatory T cell lineage commitment and maintenance Immunity 30 2009 616 625
27. M.A. Curotto de Lafaille, and J.J. Lafaille Natural and adaptive foxp3+ regulatory T cells: more of the same or a division of labor? Immunity 30 2009 626 635
28. A.M. Bilate, and J.J. Lafaille Induced CD4+Foxp3+ regulatory T cells in immune tolerance Annu Rev Immunol 30 2012 733 758
29. C.S. Hsieh, Y. Zheng, Y. Liang, J.D. Fontenot, and A.Y. Rudensky An intersection between the self-reactive regulatory and nonregulatory T cell receptor repertoires Nat Immunol 7 2006 401 410
30. D. Haribhai, J.B. Williams, S. Jia, D. Nickerson, E.G. Schmitt, and B. Edwards et al. A requisite role for induced regulatory T cells in tolerance based on expanding antigen receptor diversity Immunity 35 2011 109 122
31. S.F. Ziegler FOXP3: of mice and men Annu Rev Immunol 24 2006 209 226
32. M.R. Walker, D.J. Kasprowicz, V.H. Gersuk, A. Benard, M. Van Landeghen, and J.H. Buckner et al. Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells J Clin Invest 112 2003 1437 1443 (Pubitemid 38057697)
33. J.D. Fontenot, M.A. Gavin, and A.Y. Rudensky Foxp3 programs the development and function of CD4+CD25+ regulatory T cells Nat Immunol 4 2003 330 336 (Pubitemid 36432314)
34. S.E. Allan, L. Passerini, R. Bacchetta, N. Crellin, M. Dai, and P.C. Orban et al. The role of 2 FOXP3 isoforms in the generation of human CD4+ Tregs J Clin Invest 115 2005 3276 3284 (Pubitemid 41567592)
35. J.D. Fontenot, J.P. Rasmussen, L.M. Williams, J.L. Dooley, A.G. Farr, and A.Y. Rudensky Regulatory T cell lineage specification by the forkhead transcription factor foxp3 Immunity 22 2005 329 341 (Pubitemid 40387475)
36. K. Noma, Y. Yamaguchi, R. Okita, K. Matsuura, and T. Toge The spleen plays an immunosuppressive role in patients with gastric cancer: involvement of CD62L+ cells and TGF-beta Anticancer Res 25 2005 643 649 (Pubitemid 40470076)
37. P.A. Beavis, J. Stagg, P.K. Darcy, and M.J. Smyth CD73: a potent suppressor of antitumor immune responses Trends Immunol 115 2012 353 363
38. B. Fong, R. Jin, X. Wang, M. Safaee, D.N. Lisiero, and I. Yang et al. Monitoring of regulatory T cell frequencies and expression of CTLA-4 on T cells, before and after DC vaccination, can predict survival in GBM patients PLoS ONE 7 2012 e32614
39. L.M. Ebert, B.S. Tan, J. Browning, S. Svobodova, S.E. Russell, and N. Kirkpatrick et al. The regulatory T cell-associated transcription factor FoxP3 is expressed by tumor cells Cancer Res 68 2008 3001 3009 (Pubitemid 351556301)
40. P.E. Fecci, A.E. Sweeney, P.M. Grossi, S.K. Nair, C.A. Learn, and D.A. Mitchell et al. Systemic anti-CD25 monoclonal antibody administration safely enhances immunity in murine glioma without eliminating regulatory T cells Clin Cancer Res 12 2006 4294 4305
41. A. El Andaloussi, and M.S. Lesniak An increase in CD4+CD25+FOXP3+ regulatory T cells in tumor-infiltrating lymphocytes of human glioblastoma multiforme Neuro Oncol 8 2006 234 243 (Pubitemid 46542648)
42. S.F. Atabani, C.L. Thio, S. Divanovic, A. Trompette, Y. Belkaid, and D.L. Thomas et al. Association of CTLA4 polymorphism with regulatory T cell frequency Eur J Immunol 35 2005 2157 2162 (Pubitemid 41015054)
43. C.A. Crane, B.J. Ahn, S.J. Han, and A.T. Parsa Soluble factors secreted by glioblastoma cell lines facilitate recruitment, survival, and expansion of regulatory T cells: implications for immunotherapy Neuro Oncol 14 2012 584 595
44. S. Sakaguchi Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self Nat Immunol 6 2005 345 352 (Pubitemid 41716771)
45. P.E. Fecci, D.A. Mitchell, J.F. Whitesides, W. Xie, A.H. Friedman, and G.E. Archer et al. Increased regulatory T-cell fraction amidst a diminished CD4 compartment explains cellular immune defects in patients with malignant glioma Cancer Res 66 2006 3294 3302
46. A.B. Heimberger, M. Abou-Ghazal, C. Reina-Ortiz, D.S. Yang, W. Sun, and W. Qiao et al. Incidence and prognostic impact of FoxP3+ regulatory T cells in human gliomas Clin Cancer Res 14 2008 5166 5172
47. P. Yu, Y. Lee, W. Liu, T. Krausz, A. Chong, and H. Schreiber et al. Intratumor depletion of CD4+ cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors J Exp Med 201 2005 779 791 (Pubitemid 40395122)
48. W.F. Hickey, B.L. Hsu, and H. Kimura T-lymphocyte entry into the central nervous system J Neurosci Res 28 1991 254 260
49. A.Q. Sugihara, C.E. Rolle, and M.S. Lesniak Regulatory T cells actively infiltrate metastatic brain tumors Int J Oncol 34 2009 1533 1540
50. L.A. Morford, L.H. Elliott, S.L. Carlson, W.H. Brooks, and T.L. Roszman T cell receptor-mediated signaling is defective in T cells obtained from patients with primary intracranial tumors J Immunol 159 1997 4415 4425 (Pubitemid 127470601)
51. T.L. Roszman, W.H. Brooks, C. Steele, and L.H. Elliott Pokeweed mitogen-induced immunoglobulin secretion by peripheral blood lymphocytes from patients with primary intracranial tumors. Characterization of T helper and B cell function J Immunol 134 1985 1545 1550 (Pubitemid 15135920)
52. N.N. Tran Thang, M. Derouazi, G. Philippin, S. Arcidiaco, W. Di Berardino-Besson, and F. Masson et al. Immune infiltration of spontaneous mouse astrocytomas is dominated by immunosuppressive cells from early stages of tumor development Cancer Res 70 2010 4829 4839
53. I. Shalev, N. Selzner, W. Shyu, D. Grant, and G. Levy The role of Treg in promotion of transplant tolerance Liver Transpl 18 2012 761 770
54. K.D. McCoy, and G. Le Gros The role of CTLA-4 in the regulation of T cell immune responses Immunol Cell Biol 77 1999 1 10 (Pubitemid 29111585)
55. P.E. Fecci, H. Ochiai, D.A. Mitchell, P.M. Grossi, A.E. Sweeney, and G.E. Archer et al. Systemic CTLA-4 blockade ameliorates glioma-induced changes to the CD4+ T cell compartment without affecting regulatory T-cell function Clin Cancer Res 13 2007 2158 2167 (Pubitemid 46649886)
56. M. Mathew, M. Tam, P.A. Ott, A.C. Pavlick, S.C. Rush, and B.R. Donahue et al. Ipilimumab in melanoma with limited brain metastases treated with stereotactic radiosurgery Melanoma Res 23 2013 191 195
57. Q. Wu, X. Zhan, T. Dou, H. Chen, W. Fan, and K. Zhou et al. CTLA4 A49G polymorphism shows significant association with glioma risk in a Chinese population Biochem Genet 49 2011 190 201
58. H.O. Pae, G.S. Oh, B.M. Choi, S.C. Chae, and H.T. Chung Differential expressions of heme oxygenase-1 gene in CD25- and CD25+ subsets of human CD4+ T cells Biochem Biophys Res Commun 306 2003 701 705
59. B.M. Choi, H.O. Pae, Y.R. Jeong, G.S. Oh, C.D. Jun, and B.R. Kim et al. Overexpression of heme oxygenase (HO)-1 renders Jurkat T cells resistant to Fas-mediated apoptosis: involvement of iron released by HO-1 Free Radic Biol Med 36 2004 858 871
60. D.M. Zhao, A.M. Thornton, R.J. DiPaolo, and E.M. Shevach Activated CD4+CD25+ T cells selectively kill B lymphocytes Blood 107 2006 3925 3932 (Pubitemid 43726798)
61. A.M. Thornton, and E.M. Shevach CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production J Exp Med 188 1998 287 296 (Pubitemid 28357757)
62. N.O. Camara, F. Sebille, and R.I. Lechler Human CD4+CD25+ regulatory cells have marked and sustained effects on CD8+ T cell activation Eur J Immunol 33 2003 3473 3483 (Pubitemid 37541126)
63. G. Cantini, F. Pisati, A. Mastropietro, V. Frattini, Y. Iwakura, and G. Finocchiaro et al. A critical role for regulatory T cells in driving cytokine profiles of Th17 cells and their modulation of glioma microenvironment Cancer Immunol Immunother 60 2011 1739 1750
64. J.L. Banyer, D.C. Halliday, S.A. Thomson, and N.H. Hamilton Combinations of IFN-gamma and IL-4 induce distinct profiles of dendritic cell-associated immunoregulatory properties Genes Immun 4 2003 427 440 (Pubitemid 38967608)
65. J.L. Banyer, N.H. Hamilton, I.A. Ramshaw, and A.J. Ramsay Cytokines in innate and adaptive immunity Rev Immunogenet 2 2000 359 373 (Pubitemid 32041162)
66. R. Yoshida, S.W. Park, H. Yasui, and O. Takikawa Tryptophan degradation in transplanted tumor cells undergoing rejection J Immunol 141 1988 2819 2823 (Pubitemid 18263074)
67. A. Ksendzovsky, D. Feinstein, R. Zengou, A. Sharp, P. Polak, and T. Lichtor et al. Investigation of immunosuppressive mechanisms in a mouse glioma model J Neurooncol 93 2009 107 114
68. T.A. Moo-Young, J.W. Larson, B.A. Belt, M.C. Tan, W.G. Hawkins, and T.J. Eberlein et al. Tumor-derived TGF-beta mediates conversion of CD4+Foxp3+ regulatory T cells in a murine model of pancreas cancer J Immunother 32 2009 12 21
69. B.C. Kennedy, L.M. Maier, R. D'Amico, C.E. Mandigo, E.J. Fontana, and A. Waziri et al. Dynamics of central and peripheral immunomodulation in a murine glioma model BMC Immunol 10 2009 11
70. S.F. Hussain, D. Yang, D. Suki, K. Aldape, E. Grimm, and A.B. Heimberger The role of human glioma-infiltrating microglia/macrophages in mediating antitumor immune responses Neuro Oncol 8 2006 261 279 (Pubitemid 46542651)
71. J.F. Jacobs, A.J. Idema, K.F. Bol, J.A. Grotenhuis, I.J. de Vries, and P. Wesseling et al. Prognostic significance and mechanism of Treg infiltration in human brain tumors J Neuroimmunol 225 2010 195 199
72. C. Meyer, A. Sevko, M. Ramacher, A.V. Bazhin, C.S. Falk, and W. Osen et al. Chronic inflammation promotes myeloid-derived suppressor cell activation blocking antitumor immunity in transgenic mouse melanoma model Proc Natl Acad Sci USA 108 2011 17111 17116
73. V. Pillai, S.B. Ortega, C.K. Wang, and N.J. Karandikar Transient regulatory T-cells: a state attained by all activated human T-cells Clin Immunol 123 2007 18 29 (Pubitemid 46401504)
74. J. Wang, A. Ioan-Facsinay, E.I. van der Voort, T.W. Huizinga, and R.E. Toes Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells Eur J Immunol 37 2007 129 138 (Pubitemid 46128793)
75. V.G. Oliveira, M. Caridade, R.S. Paiva, J. Demengeot, and L. Graca Sub-optimal CD4+ T-cell activation triggers autonomous TGF-beta-dependent conversion to Foxp3+ regulatory T cells Eur J Immunol 41 2011 1249 1255
76. Y. Lu, J. Suzuki, M. Guillioli, O. Umland, and Z. Chen Induction of self-antigen-specific Foxp3+ regulatory T cells in the periphery by lymphodepletion treatment with anti-mouse thymocyte globulin in mice Immunology 134 2011 50 59
77. M.D. Sharma, D.Y. Hou, B. Baban, P.A. Koni, Y. He, and P.R. Chandler et al. Reprogrammed foxp3(+) regulatory T cells provide essential help to support cross-presentation and CD8(+) T cell priming in naive mice Immunity 33 2010 942 954
78. J. Ye, X. Su, E.C. Hsueh, Y. Zhang, J.M. Koenig, and D.F. Hoft et al. Human tumor-infiltrating Th17 cells have the capacity to differentiate into IFN-gamma+ and FOXP3+ T cells with potent suppressive function Eur J Immunol 41 2011 936 951
79. D.A. Wainwright, S. Sengupta, Y. Han, and M.S. Lesniak Thymus-derived rather than tumor-induced regulatory T cells predominate in brain tumors Neuro Oncol 13 2011 1308 1323
80. K.W. Moore, R. de Waal Malefyt, R.L. Coffman, and A. O'Garra Interleukin-10 and the interleukin-10 receptor Annu Rev Immunol 19 2001 683 765 (Pubitemid 32368050)
81. C.A. Akdis, and K. Blaser Mechanisms of interleukin-10-mediated immune suppression Immunology 103 2001 131 136 (Pubitemid 32521341)
82. E. Roussel, M.C. Gingras, E.A. Grimm, J.M. Bruner, and R.P. Moser Predominance of a type 2 intratumoural immune response in fresh tumour-infiltrating lymphocytes from human gliomas Clin Exp Immunol 105 1996 344 352 (Pubitemid 26246956)
83. B. Kaminska, M. Kocyk, and M. Kijewska TGF beta signaling and its role in glioma pathogenesis Adv Exp Med Biol 986 2013 171 187
84. R. Ueda, M. Fujita, X. Zhu, K. Sasaki, E.R. Kastenhuber, and G. Kohanbash et al. Systemic inhibition of transforming growth factor-beta in glioma-bearing mice improves the therapeutic efficacy of glioma-associated antigen peptide vaccines Clin Cancer Res 15 2009 6551 6559
85. D.A. Wainwright, I.V. Balyasnikova, A.L. Chang, A.U. Ahmed, K.S. Moon, and B. Auffinger et al. IDO expression in brain tumors increases the recruitment of regulatory T cells and negatively impacts survival Clin Cancer Res 18 2012 6110 6121
86. E.M. Shevach, and G.L. Stephens The GITR-GITRL interaction: co-stimulation or contrasuppression of regulatory activity Nat Rev Immunol 6 2006 613 618 (Pubitemid 44134094)
87. A.D. Cohen, D.A. Schaer, C. Liu, Y. Li, D. Hirschhorn-Cymmerman, and S.C. Kim et al. Agonist anti-GITR monoclonal antibody induces melanoma tumor immunity in mice by altering regulatory T cell stability and intra-tumor accumulation PLoS ONE 5 2010 e10436
88. D.A. Wainwright, M. Dey, A. Chang, and M.S. Lesniak Targeting Tregs in malignant brain cancer: overcoming IDO Front Immunol 4 2013 116
89. J. Wei, A. Wu, L.Y. Kong, Y. Wang, G. Fuller, and I. Fokt et al. Hypoxia potentiates glioma-mediated immunosuppression PLoS ONE 6 2011 e16195
90. R.L. Jensen Brain tumor hypoxia: tumorigenesis, angiogenesis, imaging, pseudoprogression, and as a therapeutic target J Neurooncol 92 2009 317 335
91. J. Ben-Shoshan, S. Maysel-Auslender, A. Mor, G. Keren, and J. George Hypoxia controls CD4+CD25+ regulatory T-cell homeostasis via hypoxia-inducible factor-1alpha Eur J Immunol 38 2008 2412 2418
92. M. Kasprzycka, M. Marzec, X. Liu, Q. Zhang, and M.A. Wasik Nucleophosmin/anaplastic lymphoma kinase (NPM/ALK) oncoprotein induces the T regulatory cell phenotype by activating STAT3 Proc Natl Acad Sci USA 103 2006 9964 9969 (Pubitemid 43993606)
93. H. Yu, M. Kortylewski, and D. Pardoll Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment Nat Rev Immunol 7 2007 41 51 (Pubitemid 46020826)
94. J.R. Pallandre, E. Brillard, G. Crehange, A. Radlovic, J.P. Remy-Martin, and P. Saas et al. Role of STAT3 in CD4+CD25+FOXP3+ regulatory lymphocyte generation: implications in graft-versus-host disease and antitumor immunity J Immunol 179 2007 7593 7604
95. C.E. Rolle, S. Sengupta, and M.S. Lesniak Mechanisms of immune evasion by gliomas Adv Exp Med Biol 746 2012 53 76
96. M. Abou-Ghazal, D.S. Yang, W. Qiao, C. Reina-Ortiz, J. Wei, and L.Y. Kong et al. The incidence, correlation with tumor-infiltrating inflammation, and prognosis of phosphorylated STAT3 expression in human gliomas Clin Cancer Res 14 2008 8228 8235
97. J. Wei, J. Barr, L.Y. Kong, Y. Wang, A. Wu, and A.K. Sharma et al. Glioblastoma cancer-initiating cells inhibit T-cell proliferation and effector responses by the signal transducers and activators of transcription 3 pathway Mol Cancer Ther 9 2010 67 78
98. B. Li, C.M. Chang, M. Yuan, W.G. McKenna, and H.K. Shu Resistance to small molecule inhibitors of epidermal growth factor receptor in malignant gliomas Cancer Res 63 2003 7443 7450 (Pubitemid 37413487)
99. L. Williams, L. Bradley, A. Smith, and B. Foxwell Signal transducer and activator of transcription 3 is the dominant mediator of the anti-inflammatory effects of IL-10 in human macrophages J Immunol 172 2004 567 576 (Pubitemid 38020514)
100. C. Rummel, C. Sachot, S. Poole, and G.N. Luheshi Circulating interleukin-6 induces fever through a STAT3-linked activation of COX-2 in the brain Am J Physiol Regul Integr Comp Physiol 291 2006 R1316 R1326
101. I. Kinjyo, H. Inoue, S. Hamano, S. Fukuyama, T. Yoshimura, and K. Koga et al. Loss of SOCS3 in T helper cells resulted in reduced immune responses and hyperproduction of interleukin 10 and transforming growth factor-beta 1 J Exp Med 203 2006 1021 1031
102. J. Lohr, T. Ratliff, A. Huppertz, Y. Ge, C. Dictus, and R. Ahmadi et al. Effector T-cell infiltration positively impacts survival of glioblastoma patients and is impaired by tumor-derived TGF-beta Clin Cancer Res 17 2011 4296 4308
103. M. Kortylewski, M. Kujawski, T. Wang, S. Wei, S. Zhang, and S. Pilon-Thomas et al. Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity Nat Med 11 2005 1314 1321 (Pubitemid 41752912)
104. A. Matsukawa, S. Kudo, T. Maeda, K. Numata, H. Watanabe, and K. Takeda et al. Stat3 in resident macrophages as a repressor protein of inflammatory response J Immunol 175 2005 3354 3359 (Pubitemid 41170557)
105. G. Frisullo, F. Angelucci, M. Caggiula, V. Nociti, R. Iorio, and A.K. Patanella et al. pSTAT1, pSTAT3, and T-bet expression in peripheral blood mononuclear cells from relapsing-remitting multiple sclerosis patients correlates with disease activity J Neurosci Res 84 2006 1027 1036 (Pubitemid 44521047)
106. B. Yaroslavskiy, S.C. Watkins, S. Alber, and R.A. Steinman Dynamic changes in p27kip1 variant expression in activated lymphocytes J Cell Biochem 83 2001 380 389 (Pubitemid 33027483)
107. E. Zorn, E.A. Nelson, M. Mohseni, F. Porcheray, H. Kim, and D. Litsa et al. IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo Blood 108 2006 1571 1579 (Pubitemid 44316124)
108. A. Soeda, M. Park, D. Lee, A. Mintz, A. Androutsellis-Theotokis, and R.D. McKay et al. Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1alpha Oncogene 28 2009 3949 3959
109. M.J. Gray, J. Zhang, L.M. Ellis, G.L. Semenza, D.B. Evans, and S.S. Watowich et al. HIF-1alpha, STAT3, CBP/p300 and Ref-1/APE are components of a transcriptional complex that regulates Src-dependent hypoxia-induced expression of VEGF in pancreatic and prostate carcinomas Oncogene 24 2005 3110 3120 (Pubitemid 40695080)
110. C.A. Crane, S.J. Han, J.J. Barry, B.J. Ahn, L.L. Lanier, and A.T. Parsa TGF-beta downregulates the activating receptor NKG2D on NK cells and CD8+ T cells in glioma patients Neuro Oncol 12 2010 7 13
111. K. Miyazono, S. Ehata, and D. Koinuma Tumor-promoting functions of transforming growth factor-beta in progression of cancer Ups J Med Sci 117 2012 143 152
112. L. Xu, H. Xiao, M. Xu, C. Zhou, L. Yi, and H. Liang Glioma-derived T cell immunoglobulin- and mucin domain-containing molecule-4 (TIM4) contributes to tumor tolerance J Biol Chem 286 2011 36694 36699
113. B. Johnson, T. Osada, T. Clay, H. Lyerly, and M. Morse Physiology and therapeutics of vascular endothelial growth factor in tumor immunosuppression Curr Mol Med 9 2009 702 707
114. J. Wang, L. Yao, S. Zhao, X. Zhang, J. Yin, and Y. Zhang et al. Granulocyte-colony stimulating factor promotes proliferation, migration and invasion in glioma cells Cancer Biol Ther 2012 13
115. J. Zhang, S. Sarkar, R. Cua, Y. Zhou, W. Hader, and V.W. Yong A dialog between glioma and microglia that promotes tumor invasiveness through the CCL2/CCR2/interleukin-6 axis Carcinogenesis 33 2012 312 319
116. M. Le Mercier, S. Fortin, V. Mathieu, R. Kiss, and F. Lefranc Galectins and gliomas Brain Pathol 20 2010 17 27
117. I.F. Parney Basic concepts in glioma immunology Adv Exp Med Biol 746 2012 42 52
118. C. Vasco, A. Canazza, A. Rizzo, A. Mossa, E. Corsini, and A. Silvani et al. Circulating T regulatory cells migration and phenotype in glioblastoma patients: an in vitro study J Neurooncol 115 2013 353 363
119. W. Maes, T. Verschuere, A. Van Hoylandt, L. Boon, and S. Van Gool Depletion of regulatory T cells in a mouse experimental glioma model through anti-CD25 treatment results in the infiltration of non-immunosuppressive myeloid cells in the brain Clin Dev Immunol 2013 2013 952469
120. B.D. Choi, P.E. Fecci, and J.H. Sampson Regulatory T cells move in when gliomas say "I Do" Clin Cancer Res 18 2012 6086 6088
121. J. Soderlund, S. Erhardt, and R.E. Kast Acyclovir inhibition of IDO to decrease Tregs as a glioblastoma treatment adjunct J Neuroinflamm 7 2010 44